Quick Summary: Community Pharmacies Highlight Asthma Support on World Asthma Day
- Asthma affects 2.8 million Australians, highlighting the need for improved care.
- 80% of asthma flare-ups are linked to viral infections, increasing urgency for new treatments.
- New guidelines recommend anti-inflammatory inhalers over traditional relievers.
- Pharmacies are expanding asthma management services across more locations.
- The National Asthma Council aligns with World Asthma Day’s theme for better inhaler access.
Source: Read original article
The Pharmacy Guild of Australia is stepping up its game, urging Queenslanders to prioritize pharmacies for asthma care. This bold move aligns with a national shift in treatment guidelines that could revolutionize asthma management.
On 5 May 2026, the Guild’s Queensland branch made a compelling case for consulting pharmacists about asthma management. With new guidelines recommending anti-inflammatory inhalers over traditional relievers, the Guild is positioning pharmacies as key players in this healthcare evolution.
Asthma Australia has underscored the significance of this change, warning that reliance on blue puffers leaves patients vulnerable to severe flare-ups. The organization is calling for coordinated national leadership to ensure these changes are implemented effectively.
As winter approaches, the urgency for updated care is amplified by a new flu strain. The National Asthma Council reports that asthma affects one in nine Australians, emphasizing the critical role pharmacies can play in providing accessible asthma services.
The Guild’s campaign is not just about awareness; it’s about action. By expanding asthma management services to more locations, pharmacies are asserting their role in frontline respiratory care. This initiative could transform public health attention into lasting change.
The council also warned that “at least 80% of asthma flare-ups” are caused by viral infection, an especially pointed figure given its simultaneous flu-vaccination push ahead of the June-to-September winter peak. On 30 April 2026, National Asthma Council Clinical Executive Lead Associate Professor Debbie Rigby warned that a “new, fast-moving strain of influenza dubbed ‘Super-K’ is circulating,” adding urgency to World Asthma Day messaging.
Pharmacy Daily, reporting on 6 May 2026, sharpened that message by saying pharmacies are now offering “more asthma management services in more locations,” framing the campaign not as a symbolic health-awareness exercise but as a claim that community pharmacies are already expanding practical access to care. Asthma Australia said on 5 May 2026 that Australia is facing “the biggest change to asthma treatment recommendations in a generation,” with updated national guidance moving adults and adolescents away from short-acting relievers alone and toward anti-inflammatory reliever treatment.
The National Asthma Council, for its part, is aligning with the 2026 World Asthma Day theme, “Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need,” and linking that agenda to both influenza vaccination and the revised Australian Asthma Handbook. 8 million people, while globally the disease affects more than 260 million and causes more than 450,000 deaths a year.
The Guild’s Queensland branch published “Breathe easier this World Asthma Day with support from your community pharmacy” on 5 May 2026, using the annual awareness day to urge Queenslanders to “Think Pharmacy First” and speak with local pharmacists about asthma management, medication use, inhaler technique and available support services. ” That introduces tension into the Guild campaign: pharmacies are publicly asserting they can help fill the implementation gap now, while advocacy groups are warning that without government action, software changes, prescribing updates and funding alignment, the benefits of the new recommendations may stall.
On 5 May, World Asthma Day itself, the Pharmacy Guild’s Queensland branch launched its pharmacy-first asthma message and Asthma Australia escalated the issue by calling for national leadership on the guideline overhaul. On 6 May, Pharmacy Daily reported that the Guild’s campaign was about expanding asthma services “in more locations,” suggesting the profession wants to convert this week’s public-health attention into a lasting role in frontline respiratory care.